Vista Pharmaceuticals Ltd — Insider Trading, 25-09-2025: Insider Trading / SAST

Vista Pharmaceuticals has announced the closure of its trading window for Designated Persons and their immediate relatives, effective October 1, 2025. This restriction on dealing or trading in company shares will remain in effect until 48 hours after the Board declares the financial results for the quarter and half-year ending September 30, 2025. This measure prevents insider trading before the company's upcoming earnings announcement, ensuring fair market practices for all stakeholders. The date of the Board meeting to consider these results will be announced soon.